Skip to main navigation

Immunocore

Primary Menu

Overview
News & Events
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
Financials & Filings
- SEC Filings
- Annual Reports
IR Resources

Primary Menu

Overview
News & Events
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
Financials & Filings
- SEC Filings
- Annual Reports
IR Resources

News Releases

Breadcrumb

Home /
Investor Relations /
News & Events /
News Releases

Year

1 June 2023

Immunocore to present at upcoming investor conferences

10 May 2023

Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update

3 May 2023

Immunocore to present at the Bank of America Securities 2023 Health Care Conference

18 April 2023

Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival

11 April 2023

Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference

14 March 2023

Immunocore to present four posters at AACR Annual Meeting 2023

1 March 2023

Immunocore Reports 2022 Financial Results and Provides Business Update

28 February 2023

Immunocore to present at upcoming investor conferences

23 February 2023

Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023

22 February 2023

Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 11 - 20 of 179

Site - Shareholder Tools

Immunocore

Site - Footer Social

About us
Our science
Our therapy areas
For patients

News
Careers
Contact us

Privacy and Social Media Guidelines
Cookies
Payments and Disclosures
Clinical trials

©2023 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd